Search research articles
Contact Us
Filters
Showing results (91-100 of 159) with videos related to
Page
of 16
Sort By:
Journal of the National Cancer Institute
|
February 18, 2015
Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235
Nitin Ohri, Fenghai Duan, Mitchell Machtay, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 2, 2008
Toward dose optimization for fractionated stereotactic radiotherapy for acoustic neuromas: comparison of two dose cohorts
David W Andrews, Maria Werner-Wasik, Robert B Den, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 20, 2012
Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for early-stage non-small cell lung cancer?
Matthias Guckenberger, Larry L Kestin, Andrew J Hope, et al.
Molecular Cancer Therapeutics
|
February 28, 2013
ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALK
Yunguang Sun, Kamila A Nowak, Nicholas G Zaorsky, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 13, 2013
The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801
Yaacov Richard Lawrence, Rebecca Paulus, Corey Langer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 17, 2012
Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer
Matthias Guckenberger, Rainer J Klement, Larry L Kestin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 23, 2015
Tumor volume threshold for achieving improved conformity in VMAT and Gamma Knife stereotactic radiosurgery for vestibular schwannoma
Hyun Kim, Peter Potrebko, Amanda Rivera, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 30, 2018
Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420
Frank S Lieberman, Meihua Wang, H Ian Robins, et al.
Ophthalmic Plastic and Reconstructive Surgery
|
March 29, 2017
Spheno-Orbital Meningiomas: An Analysis Based on World Health Organization Classification and Ki-67 Proliferative Index
Irina Belinsky, Ann P Murchison, James J Evans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 4, 2019
Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas
Andrew Song, David W Andrews, Maria Werner-Wasik, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 159) with videos related to
Sort By:
Page
of 16
Journal of the National Cancer Institute
|
February 18, 2015
Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235
Nitin Ohri, Fenghai Duan, Mitchell Machtay, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 2, 2008
Toward dose optimization for fractionated stereotactic radiotherapy for acoustic neuromas: comparison of two dose cohorts
David W Andrews, Maria Werner-Wasik, Robert B Den, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 20, 2012
Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for early-stage non-small cell lung cancer?
Matthias Guckenberger, Larry L Kestin, Andrew J Hope, et al.
Molecular Cancer Therapeutics
|
February 28, 2013
ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALK
Yunguang Sun, Kamila A Nowak, Nicholas G Zaorsky, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 13, 2013
The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801
Yaacov Richard Lawrence, Rebecca Paulus, Corey Langer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 17, 2012
Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer
Matthias Guckenberger, Rainer J Klement, Larry L Kestin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 23, 2015
Tumor volume threshold for achieving improved conformity in VMAT and Gamma Knife stereotactic radiosurgery for vestibular schwannoma
Hyun Kim, Peter Potrebko, Amanda Rivera, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 30, 2018
Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420
Frank S Lieberman, Meihua Wang, H Ian Robins, et al.
Ophthalmic Plastic and Reconstructive Surgery
|
March 29, 2017
Spheno-Orbital Meningiomas: An Analysis Based on World Health Organization Classification and Ki-67 Proliferative Index
Irina Belinsky, Ann P Murchison, James J Evans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 4, 2019
Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas
Andrew Song, David W Andrews, Maria Werner-Wasik, et al.
Page
of 16